大脑结构和神经退行性疾病的结构基础
Jiawen Yang1,2, Sen-Fang Sui2,3, Zheng Liu1
1Cryo-electron Microscopy Center, Southern University of Science and Technology, Shenzhen 518055, Guangdong, China.
Biophysics reports
|June 8, 2023
概括
研究人类大脑结构揭示了它的复杂性和与神经退行性疾病的联系. 了解这些结构变化有助于早期诊断和潜在的治疗阿尔茨海默症和帕金森症等疾病.
科学领域:
- 神经科学是一个神经科学.
- 人类大脑解剖学 人类大脑解剖学
- 神经病理学神经病理学
背景情况:
- 人类大脑是一个高度复杂的网络,由相互连接的神经元和负责各种功能的区域组成.
- 技术的进步使得在多个尺度上详细分析大脑细胞组成和地图集构造成为可能.
- 像阿尔茨海默氏症和帕金森症这样的神经精神疾病与异常的大脑结构变化有关.
研究的目的:
- 审查当前关于人类大脑结构的研究.
- 探索神经退行性疾病背后的结构机制.
- 讨论大脑结构研究的挑战和未来方向.
主要方法:
- 审查现有的文献和研究进展在人类大脑结构.
- 分析大脑绘图和细胞类型组成方面的技术进步.
- 检查大脑结构异常与神经退行性疾病病理学之间的关系.
主要成果:
- 人类大脑结构研究正在推进,提供了详细地图的新工具.
- 大脑结构的异常与主要神经退行性疾病的病理学密切相关.
- 结构洞察力为早期诊断标志物和治疗目标提供了潜力.
结论:
- 了解人类大脑结构对于破译神经退行性疾病机制至关重要.
- 对大脑结构的持续研究可以带来更好的诊断工具和治疗方法.
- 该领域面临挑战,但对未来的神经健康进展具有重大前景.
相关概念视频
Alzheimer's Disease: Overview
536
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
536
Parkinson's Disease: Overview
612
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
612
Disorders of the Nervous Tissue
1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Biological Causes of Schizophrenia
105
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
105
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K


